Prognostic impact of ACE inhibition in systemic lupus erythematosus, diabetes mellitus and chronic glomerulonephritis.
Aurell
M
M
Department of Nephrology, Sahlgrenska Sjukhuset, University of Göteborg, Sweden.
Samuelsson
O
O
Attman
P O
PO
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D002908:Chronic Disease; D003920:Diabetes Mellitus / Q000188:drug therapy* / Q000503:physiopathology; D005921:Glomerulonephritis / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy* / Q000503:physiopathology; D011379:Prognosis
D000806:Angiotensin-Converting Enzyme Inhibitors